| Literature DB >> 27755800 |
Zhuang Liu1, Meng Su1, Shi-Cheng Yu1, Zhi-Hua Yin1, Bao-Sen Zhou1.
Abstract
The role of Chlamydia pneumoniae in the cause of lung cancer is controversial. In this study, we investigated the association between C. pneumoniae immunoglobulin (Ig) G antibodies and risk of lung cancer among non-smoking women. C. pneumoniae IgG antibody levels were compared between 192 adult Chinese women who met the diagnostic criteria of lung cancer and 90 healthy controls. C. pneumoniae IgG antibodies were tested with the use of an enzyme-linked immunosorbent assay. The prevalence of C. pneumoniae IgG seropositivity was 61.98% of cases and 28.89% of controls (P < 0.05). According to the results of the multiple logistic analysis model, the odds ratios for C. pneumoniae IgG antibody seropositivity, body mass index, and educational levels were 3.919 (P < 0.001), 0.731 (P= 0.274), and 1.646 (P= 0.069), respectively. C. pneumoniae infection may be a risk factor for lung cancer. © Tianjin Lung Cancer Institute and Blackwell Publishing Asia Pty. Ltd.Entities:
Keywords: Chlamydia pneumoniae IgG antibodies; immunoglobulin; lung cancer
Year: 2010 PMID: 27755800 DOI: 10.1111/j.1759-7714.2010.00021.x
Source DB: PubMed Journal: Thorac Cancer ISSN: 1759-7706 Impact factor: 3.500